|
Name |
2-[[(1R,4aR,8aR)-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]methyl]-3-hydroxy-5-(hydroxymethyl)cyclohexa-2,5-diene-1,4-dione
|
| Molecular Formula | C22H30O4 | |
| IUPAC Name* |
2-[[(1R,4aR,8aR)-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]methyl]-3-hydroxy-5-(hydroxymethyl)cyclohexa-2,5-diene-1,4-dione
|
|
| SMILES |
C[C@@]12CCCC([C@H]1CCC(=C)[C@H]2CC3=C(C(=O)C(=CC3=O)CO)O)(C)C
|
|
| InChI |
InChI=1S/C22H30O4/c1-13-6-7-18-21(2,3)8-5-9-22(18,4)16(13)11-15-17(24)10-14(12-23)19(25)20(15)26/h10,16,18,23,26H,1,5-9,11-12H2,2-4H3/t16-,18-,22+/m1/s1
|
|
| InChIKey |
KNEPVLLGXUSFJS-CDMIOBSGSA-N
|
|
| Synonyms |
tauranin; 6752-85-8
|
|
| CAS | NA | |
| PubChem CID | 101967117 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 358.5 | ALogp: | 4.4 |
| HBD: | 2 | HBA: | 4 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 74.6 | Aromatic Rings: | 3 |
| Heavy Atoms: | 26 | QED Weighted: | 0.568 |
| Caco-2 Permeability: | -4.876 | MDCK Permeability: | 0.00001740 |
| Pgp-inhibitor: | 0.408 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.992 |
| 30% Bioavailability (F30%): | 0.89 |
| Blood-Brain-Barrier Penetration (BBB): | 0.079 | Plasma Protein Binding (PPB): | 99.06% |
| Volume Distribution (VD): | 3.64 | Fu: | 1.28% |
| CYP1A2-inhibitor: | 0.191 | CYP1A2-substrate: | 0.794 |
| CYP2C19-inhibitor: | 0.403 | CYP2C19-substrate: | 0.367 |
| CYP2C9-inhibitor: | 0.41 | CYP2C9-substrate: | 0.949 |
| CYP2D6-inhibitor: | 0.373 | CYP2D6-substrate: | 0.477 |
| CYP3A4-inhibitor: | 0.165 | CYP3A4-substrate: | 0.146 |
| Clearance (CL): | 3.874 | Half-life (T1/2): | 0.698 |
| hERG Blockers: | 0.004 | Human Hepatotoxicity (H-HT): | 0.038 |
| Drug-inuced Liver Injury (DILI): | 0.032 | AMES Toxicity: | 0.113 |
| Rat Oral Acute Toxicity: | 0.116 | Maximum Recommended Daily Dose: | 0.335 |
| Skin Sensitization: | 0.92 | Carcinogencity: | 0.037 |
| Eye Corrosion: | 0.025 | Eye Irritation: | 0.918 |
| Respiratory Toxicity: | 0.87 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002494 | ![]() |
0.810 | D04VIS | ![]() |
0.353 | ||
| ENC002490 | ![]() |
0.753 | D0S0NK | ![]() |
0.344 | ||
| ENC002493 | ![]() |
0.753 | D01CKY | ![]() |
0.275 | ||
| ENC000956 | ![]() |
0.548 | D0D2VS | ![]() |
0.272 | ||
| ENC002492 | ![]() |
0.511 | D0IX6I | ![]() |
0.270 | ||
| ENC002141 | ![]() |
0.459 | D0G8BV | ![]() |
0.264 | ||
| ENC002491 | ![]() |
0.439 | D0IL7L | ![]() |
0.259 | ||
| ENC003143 | ![]() |
0.414 | D0F2AK | ![]() |
0.257 | ||
| ENC005585 | ![]() |
0.396 | D04ATM | ![]() |
0.252 | ||
| ENC001844 | ![]() |
0.396 | D0L2LS | ![]() |
0.250 | ||